Fluticasone propionate
- Generic Name
- Fluticasone propionate
- Brand Names
- Advair, Airduo, Airduo Respiclick, Aller-flo, Armonair, Beser, Cutivate, Dymista, Flonase, Flovent, Fluticare, Ticanase, Wixela, Xhance
- Drug Type
- Small Molecule
- Chemical Formula
- C25H31F3O5S
- CAS Number
- 80474-14-2
- Unique Ingredient Identifier
- O2GMZ0LF5W
- Background
Fluticasone propionate is a synthetic glucocorticoid. These drugs are available as inhalers, nasal, sprays, and topical treatments for various inflammatory indications. Fluticasone propionate was first approved in 1990.
- Indication
Fluticasone propionate is indicated as an inhaler for the treatment and management of asthma by prophylaxisas well as inflammatory and pruritic dermatoses. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis.
- Associated Conditions
- Allergic Rhinitis (AR), Allergy to Animal Dander, Allergy to Mold, Allergy to Tree Pollen, Asthma, Bacterial Sinusitis, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Chronic Sinusitis, Dermatitis, Emphysema, Eosinophilic Esophagitis, House Dust Mite Allergy, House dust allergy, Itching of the nose, Nasal Congestion, Non-Allergic Rhinitis, Rhinitis, Rhinitis Perennial, Rhinorrhoea, Seasonal Allergic Rhinitis, Sneezing, Moderate, severe Perennial Allergic Rhinitis (PAR), Moderate, severe Seasonal Allergic Rhinitis
- Associated Therapies
- -
Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate
- First Posted Date
- 2014-09-04
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Kindeva Drug Delivery
- Target Recruit Count
- 52
- Registration Number
- NCT02232087
- Locations
- 🇬🇧
Quotient Clinical Ltd, Ruddington, Nottingham, United Kingdom
Effects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPD
- Conditions
- Interventions
- First Posted Date
- 2014-08-06
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- Hospital Son Llatzer
- Target Recruit Count
- 23
- Registration Number
- NCT02209974
- Locations
- 🇪🇸
Hospital Son Llatzer, Palma de Mallorca, Baleares, Spain
Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment
- Conditions
- Interventions
- First Posted Date
- 2014-05-19
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 31
- Registration Number
- NCT02141633
- Locations
- 🇺🇸
University of Miami School of Medicine, Miami, Florida, United States
Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD
- Conditions
- Interventions
- First Posted Date
- 2014-02-05
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 222
- Registration Number
- NCT02055352
- Locations
- 🇵🇦
Novartis Investigative Site, Panama City, Panamá, Panama
Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients
- Conditions
- Interventions
- First Posted Date
- 2013-10-25
- Last Posted Date
- 2016-02-12
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 229
- Registration Number
- NCT01969721
- Locations
- 🇨🇿
1237.11.42004 Boehringer Ingelheim Investigational Site, Rokycany, Czech Republic
🇩🇪1237.11.49003 Boehringer Ingelheim Investigational Site, Großhansdorf, Germany
🇩🇪1237.11.49005 Boehringer Ingelheim Investigational Site, Hamburg, Germany
A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic Dermatitis
- First Posted Date
- 2013-08-05
- Last Posted Date
- 2018-10-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 107
- Registration Number
- NCT01915914
- Locations
- 🇨🇳
GSK Investigational Site, Shanghai, China
Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma
- Conditions
- Interventions
- First Posted Date
- 2013-06-19
- Last Posted Date
- 2020-05-18
- Lead Sponsor
- Rhode Island Hospital
- Target Recruit Count
- 118
- Registration Number
- NCT01881412
- Locations
- 🇺🇸
Rhode Island Hospital / Hasbro Children's Hospital, Providence, Rhode Island, United States
Qvar vs FP in Pediatrics
- Conditions
- Interventions
- First Posted Date
- 2013-06-14
- Last Posted Date
- 2013-06-14
- Lead Sponsor
- Research in Real-Life Ltd
- Target Recruit Count
- 2654
- Registration Number
- NCT01877954
Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis
- Conditions
- Interventions
- First Posted Date
- 2013-05-06
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- Azienda Policlinico Umberto I
- Target Recruit Count
- 64
- Registration Number
- NCT01846962
- Locations
- 🇮🇹
Departments of Pediatrics, Sapienza - University of Rome, Rome, Italy
Assessment of Fluticasone Propionate on Ocular Allergy Symptoms
- Conditions
- Interventions
- First Posted Date
- 2013-03-25
- Last Posted Date
- 2014-04-03
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 626
- Registration Number
- NCT01817790
- Locations
- 🇺🇸
PPD Corporate Headquarters, Wilmington, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.